Table 2.

EphA5 Silencing Leading to a Defective G1/S Checkpoint in ESCC Cells

Non-Irradiated
	KYSE150				KYSE450
Treatment	G1(%)	S(%)	G2/M(%)	G1/S(ratio)		G1(%)	S(%)	G2/M(%)	G1/S(ratio)
NC	53.71±0.66	39.17±0.95	7.12±1.61	1.37±0.017		54.95±0.82	41.31±0.54	3.74±1.09	1.33±0.024
siEphA5	53.68±0.88	40.55±0.53	5.77±1.41	1.32±0.006		56.53±0.58	41.4±0.40	2.04±0.94	1.36±0.006
8Gy
	KYSE150					KYSE450
Treatment	G1(%)	S(%)	G2/M(%)	G1/S(ratio)		G1(%)	S(%)	G2/M(%)	G1/S(ratio)
NC	22.69±1.27	8.68±0.89	68.63±2.15	2.62±0.12		4.84±0.17	10.44±0.64	84.72±0.80	0.46±0.013
siEphA5	27.21±0.99	13.79±0.78	59.0±1.71	1.98±0.06		3.36±0.45	19.90±0.16	76.74±0.59	0.17±0.021